La C. Da
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 06, 2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer.
Journal: European urology oncology
Published: January 07, 2024
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.
Journal: Frontiers in oncology
Published: August 13, 2022
The CUSUM curve combined with comprehensive complication index for assessing short-term complications of radical cystectomy.
Journal: Journal of clinical laboratory analysis
Published: March 01, 2022
Metabolism response of grazing yak to dietary concentrate supplementation in warm season.
Journal: Animal : an international journal of animal bioscience
Published: June 25, 2020
Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer.
Journal: Combinatorial chemistry & high throughput screening
Published: April 22, 2020
Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
Journal: Cancer medicine
Published: December 01, 2019
Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Journal: Oncology reports
Published: November 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026